Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome

被引:0
作者
Sipek-Dolnicar, A
Hojnik, M
Rozman, B
Vizjak, A
Ferluga, D
机构
[1] Univ Ljubljana, Med Ctr, Dept Rheumatol, Ljubljana 61000, Slovenia
[2] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia
关键词
anticardiolipin antibodies; systemic lupus erythematosus; antiphospholipid syndrome; thrombosis; thrombotic thrombocytopenic purpura;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiphospholipid syndrome has been defined by the presence of antiphospholipid antibodies or lupus anticoagulant in association with certain clinical events, including recurrent arterial or venous thromboses and recurrent fetal loss. It comprises two separate clinical entities: simple, characterized by large vessel occlusions, and catastrophic, with multiple occlusive events predominantly affecting small vessels. Three patients with systemic lupus erythematosus and permanently increased IgG anticardiolipin antibody levels are being described. Only postmortem histopathological examination revealed microangiopathic thrombotic changes in different organs, which were clinically silent in early stages of the disease and misinterpreted later in its course because of a peculiar clinical picture. All patients presented features of catastrophic antiphospholipid syndrome in the final stage of the disease.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [1] Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy
    Ruiz-Irastorza, G
    Khamashta, MA
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 606 - 612
  • [2] RENAL THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROME
    HUGHSON, MD
    NADASDY, T
    MCCARTY, GA
    SHOLER, C
    MIN, KW
    SILVA, F
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (02) : 150 - 158
  • [3] Mesenteric venous thrombosis in a patient with antiphospholipid syndrome and systemic lupus erythematosus
    Yong, Zhang
    Wang, Liping
    Chen, Jian
    Zhuang, Yongze
    ASIAN BIOMEDICINE, 2013, 7 (05) : 711 - 714
  • [4] Determinants of Risk for Venous and Arterial Thrombosis in Primary Antiphospholipid Syndrome and in Antiphospholipid Syndrome with Systemic Lupus Erythematosus
    Danowski, Adriana
    Leitao de Azevedo, Mario Newton
    de Souza Papi, Jose Angelo
    Petri, Michelle
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1195 - 1199
  • [5] Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus
    Kotzen, Elizabeth S.
    Roy, Sanjeet
    Jain, Koyal
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (05) : 376 - 386
  • [6] Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus
    Martínez-Berriotxoa, A
    Ruiz-Irastorza, G
    Egrubide, MV
    Rueda, M
    Aguirre, C
    LUPUS, 2004, 13 (12) : 927 - 933
  • [7] Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    Reshetnyak, Tatiana
    Nurbaeva, Kamila
    Ptashnik, Ivan
    Kudriaeva, Anna
    Belogurov Jr, Alexey
    Lila, Aleksandr
    Nasonov, Evgeny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [8] Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome
    Kokosi, Maria
    Lams, Boris
    Agarwal, Sangita
    CLINICS IN CHEST MEDICINE, 2019, 40 (03) : 519 - +
  • [9] Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Sammaritano, L. R.
    LUPUS, 2014, 23 (12) : 1242 - 1245
  • [10] Management of Antiphospholipid Syndrome in Patients with Systemic Lupus Erythematosus
    Mary-Clair Yelovich
    Kimberly J. Legault
    Current Treatment Options in Rheumatology, 2019, 5 : 190 - 200